Associations Between Hormonal Biomarkers and Preterm Infant Health and Development During the First 2 Years After

June Cho1, Lung-Chang Chien2, Diane Holditch-Davis3

  • 1School of Nursing, University of Nevada, Las Vegas, NV, USA.

Insights

Elevated testosterone in preterm infants may indicate risks for poor physical growth and development. Higher testosterone levels were linked to decreased body weight, length, and head circumference in very-low-birthweight infants.

Area of Science:

  • Neonatal health
  • Endocrinology
  • Developmental pediatrics

Background:

  • Testosterone levels are explored for infant health and developmental issues, aligning with gender difference theories and the extreme male brain theory of autism.
  • Testosterone, a key androgen, is elevated in preterm infants, prompting investigation into its role in neonatal health.

Purpose of the Study:

  • To investigate the relationship between hypothalamic pituitary hormones (testosterone and cortisol) and the physical growth, health, and development of very-low-birthweight (VLBW) infants.
  • To assess if testosterone and cortisol levels correlate with growth and developmental outcomes in VLBW infants.

Main Methods:

  • A comparative longitudinal study involving 40 VLBW infants.
  • Data collection included medical records, questionnaires, and infant development assessments at 6, 12, and 24 months.
  • Saliva samples were collected and hormones measured using enzyme-immunoassays.

Main Results:

  • A 1pg/ml increase in testosterone was associated with a decrease in body weight (-0.42%), length (-0.18%), and head circumference (-0.10%).
  • Cortisol levels showed no association with the measured outcomes.
  • Significant interactions between testosterone levels and time were observed concerning physical growth and socioemotional development.

Conclusions:

  • Elevated testosterone may serve as a biological risk factor for impaired infant growth and development.
  • Prenatal testosterone theories may aid in predicting health and developmental trajectories in VLBW infants.
  • Further research is needed to understand long-term socioemotional and behavioral outcomes beyond two years.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
412
Socioemotional Development during Infancy01:30

Socioemotional Development during Infancy

Socio-emotional development in infancy is primarily shaped by early emotional responses and social connections, with temperament playing a central role. Temperament refers to the consistent patterns in an individual's emotional and behavioral responses, observable even in infancy. By examining temperament, researchers can better understand an infant's unique ways of interacting with the world, influencing subsequent personality and socio-emotional growth.
Primary Temperament Types
318
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
637
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.8K
Hormonal Regulation01:40

Hormonal Regulation

Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
47.3K